1BOISSIER S,MAGNETTO S,FRAAPPART L,et al.Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices[J].Cancer Res,1997,57(18):3890-3894. 被引量：1
2THERIAULT R L,LIPTON A,HORTOBAGYI G N,et al.Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions:a randomized,placebo-controlled trial[J].J Clin Oncol,1999,17(3):846-854. 被引量：1
6[1]Woodhouse EC,Chuaqui RF,Liotta LA.General mechanisms of metastasis.Cancer,1997,80 (8):1529-1537. 被引量：1
7[2]Berning D,Schaefer U,Willich N,et al.Combination of radiotherapy and ibandronae in metastatic bone disease-results of a randomize study.Intl Radiat Oncol Bio Phys,2005,54(2):308-309. 被引量：1
8Hortobagiv GN,Theriault RL,Porter L,et al.Efficacy of pam idronate in reducing skeletal comp lications patients with breast cancer and lytlc bone metastases[J].N Engl J Med,2002,35:1785. 被引量：1
9Berenson JR,Lichtenstein A,Porter L,et al.Efficacy of pam idronate in reducing skeletal events in patients with aclvanced mutiplem yeloma[J].N Engl J Med,2001,34:488. 被引量：1
